57.79 -0.81 (-1.38%)

Near 52W High of $60.12

2.0M XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Acquisition
Sanofi to acquire Dren Bio's autoimmune treatment in a deal worth up to $1.9 billion See details

Sanofi - ADR - SNY - stock price prediction, stock price target, analyst ratings from 8 analysts

Sanofi - ADR has a share price target of US$ 64, revenue growth forecast of 18.1%, and profit growth estimate of 78.0% for FY25, based on top 8 analyst calls.